- Home
- KRMD vs OPRX Comparison
KRMD vs OPRX Comparison
Compare KRMD & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- OPRX
- Stock Information
- Founded
- KRMD 1980
- OPRX 2006
- Country
- KRMD United States
- OPRX United States
- Employees
- KRMD N/A
- OPRX N/A
- Industry
- KRMD Medical/Dental Instruments
- OPRX Business Services
- Sector
- KRMD Health Care
- OPRX Consumer Discretionary
- Exchange
- KRMD Nasdaq
- OPRX Nasdaq
- Market Cap
- KRMD 134.3M
- OPRX 154.9M
- IPO Year
- KRMD N/A
- OPRX N/A
- Fundamental
- Price
- KRMD $3.62
- OPRX $13.43
- Analyst Decision
- KRMD Strong Buy
- OPRX Buy
- Analyst Count
- KRMD 4
- OPRX 8
- Target Price
- KRMD $4.63
- OPRX $10.81
- AVG Volume (30 Days)
- KRMD 456.1K
- OPRX 321.9K
- Earning Date
- KRMD 08-06-2025
- OPRX 08-07-2025
- Dividend Yield
- KRMD N/A
- OPRX N/A
- EPS Growth
- KRMD N/A
- OPRX N/A
- EPS
- KRMD N/A
- OPRX N/A
- Revenue
- KRMD $35,083,740.00
- OPRX $94,365,000.00
- Revenue This Year
- KRMD $18.16
- OPRX $14.44
- Revenue Next Year
- KRMD $14.60
- OPRX $10.63
- P/E Ratio
- KRMD N/A
- OPRX N/A
- Revenue Growth
- KRMD 19.65
- OPRX 20.66
- 52 Week Low
- KRMD $1.86
- OPRX $3.78
- 52 Week High
- KRMD $5.05
- OPRX $15.71
- Technical
- Relative Strength Index (RSI)
- KRMD 68.65
- OPRX 54.11
- Support Level
- KRMD $3.45
- OPRX $12.56
- Resistance Level
- KRMD $3.77
- OPRX $14.06
- Average True Range (ATR)
- KRMD 0.22
- OPRX 0.72
- MACD
- KRMD 0.02
- OPRX -0.17
- Stochastic Oscillator
- KRMD 85.48
- OPRX 43.77
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.